ema prac semaglutide naion label update 2025 Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs Suboptimal therapeutic responses associated with

Patients with well-controlled Crohn's disease in remission may be considered differently than those with active inflammation, frequent flares, or complications such as strictures or fistulas

In one systematic review, roughly half to two-thirds of perimenopausal women reported hot flashes or night sweats, so overlap is the rule, not the exception

The consequence in terms of chronic disease of these addictive drugs is actually gigantic in our society, Leggio said.

In November, the company launched a GLP-1 tracker amid ongoing shortages of the medications

While certain medications used to treat autoimmune conditions can reduce the risk of CVD, there is a need to explore more effective options